shutterstock_1399766828_jisoo_song
12 December 2023FeaturesAsiaYoung Kim, Yu-Seog WON, In Hwan Kim and Amy (Seung-Hyun) Oh

Why did a South Korea court invoke the ‘extraterritorial activity’ exception in Prevenar 13 case?

In a patent infringement action filed by Pfizer, the Seoul Central District Court rendered a decision finding that another pharmaceutical company directly infringed Pfizer's composition patent—even though the infringer did not make the patented composition in Korea.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
6 January 2026   Danish pharma giant notches an important victory in a huge market for semaglutide, but faces a patent cliff and mounting challenges across India, Canada and the US.
Asia
9 December 2025   The Danish pharma giant is expanding its patent defence in India as multiple generics prepare to challenge its blockbuster diabetes and weight-loss drug ahead of 2026 patent expiry.
Asia
4 December 2025   The Delhi High Court has denied an injunction against an Indian generic manufacturer, finding credible challenges to the validity of Novo's semaglutide patent—flagging concerns over obviousness, double patenting, and evergreening.